CTSH

Cognizant Technology Solutions
D

CTSH

Arincen83/100B

Cognizant Technology Solutions revenue 1998–2026

Cognizant Technology Solutions's revenue in Q3 FY2026, the three months to 30 September 2026, was 5.66B USD, up 4.6% on the same quarter a year before. Cognizant Technology Solutions's revenue over the last twelve months was 21.89B USD, up 5.0% on the twelve months before. In fiscal year 2025 it was 21.11B USD, up 7.0% on the year before.

Last updated 6 Nov 2026 · Next report 3 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 202621.89B+4.96%7.01B2.57B
FY202531 Dec 202521.11B+6.95%7.12B2.23B
FY202431 Dec 202419.74B+1.98%6.78B2.24B
FY202331 Dec 202319.35B-0.39%6.69B2.13B
FY202231 Dec 202219.43B+4.98%6.98B2.29B
FY202131 Dec 202118.51B+11.14%6.90B2.14B
FY202031 Dec 202016.65B-0.78%5.98B1.39B
FY201931 Dec 201916.78B+4.08%6.15B1.84B
FY201831 Dec 201816.13B+8.88%6.29B2.10B
FY201731 Dec 201714.81B+9.81%5.66B1.50B
FY201631 Dec 201613.49B+8.63%5.38B1.55B
FY201531 Dec 201512.42B+20.98%4.98B1.62B
FY201431 Dec 201410.26B+16.06%4.12B1.44B
FY201331 Dec 20138.84B+20.37%3.58B1.23B
FY201231 Dec 20127.35B+20.02%3.07B1.05B
FY201131 Dec 20116.12B+33.29%2.58B883.62M
FY201031 Dec 20104.59B+40.07%1.94B733.54M
FY200931 Dec 20093.28B+16.42%1.43B534.96M
FY200831 Dec 20082.82B+31.88%1.24B430.85M
FY200731 Dec 20072.14B+49.94%929.54M350.13M
FY200631 Dec 20061.42B+60.78%636.34M232.80M
FY200531 Dec 2005885.83M+50.99%405.92M166.27M
FY200431 Dec 2004586.67M+59.32%266.86M100.24M
FY200331 Dec 2003368.23M+60.74%168.51M57.37M
FY200231 Dec 2002229.09M+28.86%106.39M34.56M
FY200131 Dec 2001177.78M+29.74%86.93M22.16M
FY200031 Dec 2000137.03M+54.14%66.59M17.68M
FY199931 Dec 199988.90M+51.71%42.70M11.20M
FY199831 Dec 199858.60M—26.70M6.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Cognizant Technology Solutions revenue growth by segment

Q3 FY2026 against Q3 FY2025

Financial Services1.77B
+12.0%
Healthcare1.59B
-1.1%
Products and Resources1.37B
-0.9%
Communication, Media and Technology939.00M
+10.5%

Cognizant Technology Solutions revenue by segment over time

Healthcare Financial Services Products and Resources Communication, Media and Technology
Fiscal yearHealthcareFinancial ServicesProducts and ResourcesCommunication, Media and Technology
FY20256.35B +7.0%6.17B +7.3%5.29B +10.5%3.30B +1.0%
FY20245.93B +4.5%5.75B -1.0%4.78B +3.3%3.27B +0.8%
FY20235.67B +0.8%5.81B -4.3%4.63B +1.4%3.24B +2.6%
FY20225.63B +5.5%6.07B +0.3%4.57B +6.8%3.16B +11.1%
FY20215.34B +158.3%6.05B +213.5%4.28B +195.5%2.84B +176.8%
FY20202.07B -56.0%1.93B -67.1%1.45B -61.6%1.03B -58.1%
FY20194.70B +0.6%5.87B +0.4%3.77B +10.4%2.45B +11.5%
FY20184.67B +9.5%5.85B +3.7%3.42B +12.3%2.20B +17.4%
FY20174.26B +10.1%5.64B +5.0%3.04B 1.87B
FY20163.87B +5.5%5.37B +7.3%— —

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Cognizant Technology Solutions's revenue

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.